908 Devices Inc. Share Price
NASDAQ: MASS | Small Cap908 Devices Inc. Stock Performance
Open $11.05 | Prev. Close $11.06 | Circuit Range N/A |
Day Range $10.56 - $11.05 | Year Range $5.03 - $11.18 | Volume 17,383 |
Average Traded $10.69 |
908 Devices Inc. Share Price Today
As of 30 August 2026, 908 Devices Inc.'s share price is $10.73. The stock opened at $11.05, compared to its previous close of $11.06. During today's trading session, 908 Devices Inc.'s share price traded between $10.56 and $11.05, with an average price of $10.80. Over the past 52 weeks, the stock has recorded a high of $11.18 and a low of $5.03. In terms of performance, 908 Devices Inc.'s share price has risen by 55.06% over the last six months and is up 71.96% on a year-on-year basis.
908 Devices Inc. Share Price Chart
908 Devices Inc. Stock Fundamentals & Key Indicators
Market Cap $385.19M | PE Ratio (TTM) 19.87 | Dividend Yield N/A |
EPS (TTM) $0.54 | Revenue (TTM) $56.20M | Return On Equity (TTM) -23.16% |
Profit Margin -59.21% | Debt to Equity 0.24 | Quarterly Earnings Growth YoY 100.00% |
908 Devices Inc. Quarterly Profit & Loss
All figures in USD
908 Devices Inc. Annual Profit & Loss
All figures in USD
About 908 Devices Inc.
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as process fingerprint data to support large-scale efforts in predictive bioprocess modeling. The company's products comprise Maven, an on-line device for bioprocess monitoring and control; Trace C2, an on-line monitoring of methanol or ethanol and control of substrate feeding in fermentation processes; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
908 Devices Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $8.25 | $11.06 | +38.25% |
Jul 2026 | $8.87 | $8.00 | -7.94% |
Jun 2026 | $8.17 | $8.69 | +2.96% |
May 2026 | $6.90 | $8.44 | +23.75% |
Apr 2026 | $6.29 | $6.82 | +11.26% |
Mar 2026 | $6.92 | $6.13 | -11.42% |
Feb 2026 | $6.10 | $6.92 | +9.49% |
Jan 2026 | $5.21 | $6.32 | +20.61% |
Dec 2025 | $6.14 | $5.24 | -17.35% |
Nov 2025 | $7.98 | $6.34 | -20.55% |
Oct 2025 | $8.74 | $7.98 | -8.90% |
Sep 2025 | $6.15 | $8.76 | +40.38% |